This funding opportunity supports original clinical and translational research proposals targeting unmet needs in pancreatic, liver, oesophageal, and gastric cancers. Priority areas include biomarker identification and validation, improved early-stage treatments, novel therapeutic combinations addressing tumor microenvironment and resistance, and inclusive trial designs to enhance participation. Proposals are reviewed by the Clinical Research Committee and funded through Cancer Research UK's clinical research funding scheme in biannual rounds.
Open to researchers applying through Cancer Research UK's clinical research funding scheme. Eligible proposals must address clinical and translational questions in the specified upper GI cancers and align with priority areas of unmet need.
